Bharat Biotech’s Covaxin gets endorsement for Phase III preliminaries: Reports Kumar Jeetendra | October 23, 2020 Bharat Biotech’s coronavirus vaccine Covaxin has obtained approval for carrying out Phase III trials on October 22, reports suggest. The approvals were reportedly given after analyzing data from Phase I and II and animal challenge study. Phase III is very likely to start next month, Business Today reported. The report stated a professional committee met …
Aurobindo Pharma agreement: CCMB creating evidence of idea for COVID-19 antibody Kumar Jeetendra | October 22, 2020 Hyderabad, Oct 22 (PTI) The CSIR-Centre for Cellular and Molecular Biology has set in motion the procedure for development of a COVID-19 vaccine candidate as part of a pact with Aurobindo Pharma, a top official of the premier institute said on Thursday. It had been in the process of creating a proof of concept for …
Poor intimate hygiene linked to being one of the biggest causes of cervical cancer Kumar Jeetendra | October 22, 2020 Cervical cancer is becoming one of the emerging health burdens for womanhood. Cervical cancer is the fourth most common type of cancer for women worldwide, but also one of the most preventable types of cancer. Most cervical cancer cases are caused by the sexually transmitted human papilloma virus (HPV). According to the data released in 2018 by the HPV Centre, in India, cervical …
SARS-CoV-2 Antibodies and Antigens for Diagnostic Kit Development Kumar Jeetendra | October 22, 2020 AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of SARS-CoV-2 antibodies and antigens to aid development of new immunoassay diagnostic kits. While RT-PCR diagnostic kits has provided fast and sensitive COVID-19 case confirmation, the technique suffers from some inherent drawbacks that limit …
US preliminary of AstraZeneca COVID-19 immunization may continue this week: Sources Kumar Jeetendra | October 21, 2020 AstraZeneca Plc’s COVID-19 vaccine trial in the United States is expected to resume as early as this week following the U.S. Food and Drug Administration completed its review of a severe illness in a study participant, four sources told Reuters. AstraZeneca’s large, late-stage U.S. trial was on hold since Sept. 6, following a participant at …
Exceptionally huge bit of COVID-19 antibodies liable to be made in India: Gates Foundation CEO Kumar Jeetendra | October 21, 2020 A very large part of COVID-19 vaccines are likely to be manufactured in India through the country’s strong and robust private sector partners,” said Bill and Melinda Gates Foundation CEO Mark Suzman. In an interview with PTI, Suzman noted that India is doing what it can right now with the tools at hand to fight …
BioGX Announces FDA Emergency Use Authorization Submission of Extraction-Free Direct RT-PCR Test for COVID-19 Kumar Jeetendra | October 21, 2020 Birmingham, AL, October 13, 2020 – Life Science Newswire – BioGX, a molecular diagnostics solutions company, announced FDA Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19. The Xfree® COVID-19 Direct RT-PCR test (“Xfree COVID-19”) is a complete test in …
BDR Pharma launches generic version of Lenvatinib for cancer patients in India Kumar Jeetendra | October 21, 2020 Mumbai, 21st October 2020: BDR Pharmaceutical today announces the launch of 4mg and 10 mg of Lenvatinib under the brand name BDFOIE for the treatment of differentiated thyroid cancer, advanced liver cancer and advanced kidney cancer. Lenvatinib is priced at INR 1620 (4 mg) and INR 2970 (10 mg) for a pack of 10 capsules. …
Researchers propose that antimalarial medications could be repurposed to treat COVID-19 Kumar Jeetendra | October 20, 2020 An international group of researchers believe there is enough evidence that anti-malarial drugs could be repurposed to treat COVID-19 and they need to be evaluated for efficacy in clinical trials. The review article, published online in Trends in Parasitology, summarizes the evidence for its antiviral and anti-inflammatory properties of particular anti-malarial drugs which could play …
Bioceramic embed can animate skull bone recovery Kumar Jeetendra | October 19, 2020 A bioceramic implant has proved to stimulate regeneration of natural skull bone, so that even large cranial defects can be repaired in a way which hasn’t been possible before. Reconstructing major bone and soft-tissue injuries in the skull after an accident or treatment of a brain tumor, blood clot, or hemorrhage is a difficult challenge. …
CBD could lessen lung harm brought about by COVID-19 Kumar Jeetendra | October 19, 2020 One way CBD appears to reduce the”cytokine storm” that damages the lungs and kills many individuals with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is proven to reduce inflammation and whose levels are dramatically reduced in the face of this storm. Dental College of Georgia and Medical …
Oxford University says COVID-19 patients experience symptoms months subsequent to contracting virus Kumar Jeetendra | October 19, 2020 Britain’s Oxford University said on Monday first findings from a study on the long term effect of COVID-19 has discovered a lot of patients discharged from hospitals still experience symptoms of breathlessness, fatigue, depression and anxiety two to three months after contracting the virus. The scientists detected abnormalities in many organs and believe persistent inflammation …
